A 2023 paper in Pharmaceuticals (PMID: 37242459) documented anxiolytic, anticonvulsive, and antidepressant-like effects in animal behavioral assays and reported that BPC-157 attenuated benzodiazepine tolerance development and counteracted serotonin syndrome in rats
Primary care or endocrinology clinicians can assess mild changes, but dermatology referral is appropriate for chronic or unclear conditions
The GLP-1 Plan is specifically built around the nutritional challenges of being on GLP-1 medication higher protein per serving to prevent muscle loss, smaller portions to match reduced appetite, and gentler ingredients for a more sensitive digestive system
These are molecules designed to mimic the action of native GLP-1, the incretin hormone your gut releases after eating
Its administration is typically via subcutaneous injection once weekly, and dosing in clinical trials has ranged from 0.5 mg to 12 mg, adjusted to optimize efficacy and tolerability